HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis, Characterization, and Anti-Cancer Activity of Some New N'-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones Derivatives.

Abstract
Eight novel N'-(2-oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazone derivatives 4a-h were synthesized and fully characterized by IR, NMR ((1)H-NMR and (13)C-NMR), elemental analysis, and X-ray crystallography. The cyto-toxicity and in vitro anti-cancer evaluation of the prepared compounds have been assessed against two different human tumour cell lines including human liver (HepG2) and leukaemia (Jurkat), as well as in normal cell lines derived from human embryonic kidney (HEK293) using MTT assay. The compounds 3e, 3f, 4a, 4c, and 4e revealed promising anti-cancer activities in tested human tumour cells lines (IC50 values between 3 and 7 μM) as compared to the known anti-cancer drug 5-Fluorouracil (IC50 32-50 μM). Among the tested compounds, 4a showed specificity against leukaemia (Jurkat) cells, with an IC50 value of 3.14 μM, but this compound was inactive in liver cancer and normal cell lines.
AuthorsAyman El-Faham, Muhammad Farooq, Sherine N Khattab, Nael Abutaha, Mohammad A Wadaan, Hazem A Ghabbour, Hoong-Kun Fun
JournalMolecules (Basel, Switzerland) (Molecules) Vol. 20 Issue 8 Pg. 14638-55 (Aug 13 2015) ISSN: 1420-3049 [Electronic] Switzerland
PMID26287132 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Hydrazones
  • Valproic Acid
  • Isatin
  • Fluorouracil
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Proliferation (drug effects)
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Fluorouracil (pharmacology)
  • HEK293 Cells
  • Hep G2 Cells
  • Humans
  • Hydrazones (chemical synthesis, chemistry, pharmacology)
  • Isatin (analogs & derivatives, chemical synthesis, chemistry, pharmacology)
  • Jurkat Cells
  • Valproic Acid (analogs & derivatives, chemical synthesis, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: